Concepedia

Errin Samuëlsz

ES

Statistics

Publications

5

Citations

463

H-Index

5

Active since

2016

Affiliations

City of Hope(Current)

Mayo Clinic Hospital

Mayo Clinic in Arizona

Errin Samuëlsz is an author at City of Hope specializing in medicine, pharmacology, and polo-like kinase inhibitors.

Publications per year

2016–2024

5

Publications

5

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Karen L. Reckamp, Vladislava O. Melnikova, Chris Karlovich et al. · Journal of Thoracic Oncology · 2016 · 285 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Amer M. Zeidan, Maya Ridinger, Tara L. Lin et al. · Clinical Cancer Research · 2020 · 89 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of <i>KRAS</i> -Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study

Daniel H. Ahn, Afsaneh Barzi, Maya Ridinger et al. · Clinical Cancer Research · 2024 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i> -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial

Daniel H. Ahn, Maya Ridinger, Timothy Lewis Cannon et al. · Journal of Clinical Oncology · 2024 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15

Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations

Jason C. Poole, Shan‐Fu Wu, Timothy T. Lu et al. · PLoS ONE · 2019 · 20 citations · Full text

Medicine, Genetics, Molecular Genetics +17

1–5 of 5